Optimal cardiometabolic health in adults may be achieved with 7 hours of sleep per night, supporting recent sleep duration recommendations, a recent study found. Using cross-sectional data from the 2005-2012 National Health and Nutrition Examination Survey, the study included 8,827 participants aged ≥20 years and sought to determine if the association of sleep duration and cardiometabolic risk score varies by subgroups. Researchers found:
- 7 hours of sleep was associated with the lowest cardiometabolic risk score.
- This score remained similar after adjusting for age, sex, ethnicity, education, family income, alcohol intake, and smoking status.
- 8 hours of sleep was associated with the lowest cardiometabolic risk score in non-Hispanic blacks.
Kanagasabai T, Chaput JP. Sleep duration and the associated cardiometabolic risk scores in adults. [Published online ahead of print April 23, 2017]. Sleep Health. doi:10.1016/j.sleh.2017.03.006.
This study looked at the relationship between sleep duration and cardiometabolic health as assessed by measurement of HDL cholesterol (HDL), waist circumference (WC), fasting insulin, fasting plasma glucose (Glu), triglycerides (TG), body mass index (BMI), systolic blood pressure (SBP) and diastolic blood pressure (DBP). The problem with studies like this is that while it appears that 7-8 hours of sleep is correlated with optimal cardiometabolic health, it is likely that the optimal sleep duration varies by individual, with different people optimally needing different amounts of sleep. Nonetheless, this study supports a benefit for most people need 7-8 hours of sleep per night. —Neil Skolnik, MD
This Week's Must Reads
Tdap Immunization & Neonatal Pertussis Antibodies, JAMA; 2018 Oct 9; Healy, Rench, et al
Influenza Vaccine Effectiveness During Pregnancy, Clin Infect Dis; ePub 2018 Oct 11; Thompson, et al
Vaccination Coverage & Exemption Rates in Children, MMWR; 2018 Oct 12; Mellerson, Maxwell, et al
Severe Pertussis Infections in All Age Groups, Clin Infect Dis; ePub 2018 Oct 15; Mbayei, et al
Influenza Vaccine Type Preference Among Parents, Vaccine; ePub 2018 Oct 16; Santibanez, et al
Must Reads in Cardiology
Treating Low-Risk Patients with Mild Hypertension, JAMA Intern Med; ePub 2018 Oct 29; Sheppard, et al
Concomitant DOAC-Antiplatelet Use & Bleeding Risk, Am J Med; ePub 2018 Oct 25; Douros, et al
Omega 3 Polyunsaturated Fatty Acids & Healthy Aging, BMJ; ePub 2018 Oct 17; Lai, Otto, et al
Kidney Damage Biomarkers & Incident CKD in BP Reduction, Ann Intern Med; ePub 2018 Oct 23; Zhang, et al
Excess Hypertension Risk in Black Adults, JAMA; 2018 Oct 8; Howard, Cushman, et al